Compound (COMP) presents a strongly positive short-term price picture. At $26.39, it is up 13.15% over 24 hours and 12.93% over seven days, with gains of 39.73% over 14 days and 42.24% over 30 days. The supplied evidence therefore favors continued upward momentum, though the latest sharp daily rise also increases the risk of a near-term pullback.

All five hourly moving averages are below the current price: the 8-, 13-, and 21-hour averages are around $24.87–$24.92, while the 55- and 144-hour averages are $24.08 and $23.98. Their reported gaps from price range from 5.88% to 10.05%, indicating that price strength is broad across the listed averages rather than limited to the shortest one.

The 1-hour RSI of 68 signals strong recent momentum and is close to, but below, the commonly watched 70 level. The 7-day RSI of 58 is less stretched and also sits above the midpoint, supporting a positive medium-term reading while tempering the concern that the move is already excessively overbought.

Momentum is positive across all three reported periods, but the 14- and 30-day gains substantially exceed the seven-day gain. This indicates that COMP has advanced considerably over the past month, while the most recent week has also remained positive; it does not, by itself, establish whether the pace of gains will continue.

Trading activity is substantial in absolute terms, with 24-hour volume of 41,654,455 and volume equal to 15.78% of market capitalization. The price is $0.53 below its 24-hour high of $26.92 and $3.15 above its low of $23.24, placing it near the top of that day’s range; the supplied volume figure alone does not show whether activity was predominantly buying or selling.

The main longer-term caution is the distance from the listed all-time high of $854.45: the current price is about 96.9% below it. That historical comparison highlights the scale of the decline from the peak, but the provided data does not establish a path back toward it or identify a specific price level that would act as support or resistance.

Overall rating: Buy. The strongest evidence is COMP’s 13.15% daily gain, positive returns over seven, 14, and 30 days, and price above every supplied hourly moving average, with the 7-day RSI remaining moderate at 58. The near-70 hourly RSI and rapid recent advance argue for caution, but they do not outweigh the alignment of the supplied trend signals.